179 related articles for article (PubMed ID: 17407277)
1. Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expression.
Guerrero MD; Aquino M; Bruno I; Terencio MC; Paya M; Riccio R; Gomez-Paloma L
J Med Chem; 2007 May; 50(9):2176-84. PubMed ID: 17407277
[TBL] [Abstract][Full Text] [Related]
2. Development of a second generation of inhibitors of microsomal prostaglandin E synthase 1 expression bearing the gamma-hydroxybutenolide scaffold.
Aquino M; Guerrero MD; Bruno I; Terencio MC; Paya M; Riccio R
Bioorg Med Chem; 2008 Oct; 16(19):9056-64. PubMed ID: 18790649
[TBL] [Abstract][Full Text] [Related]
3. Toward the discovery of new agents able to inhibit the expression of microsomal prostaglandin E synthase-1 enzyme as promising tools in drug development.
De Simone R; Andrés RM; Aquino M; Bruno I; Guerrero MD; Terencio MC; Paya M; Riccio R
Chem Biol Drug Des; 2010 Jul; 76(1):17-24. PubMed ID: 20492447
[TBL] [Abstract][Full Text] [Related]
4. Identification of new γ-hydroxybutenolides that preferentially inhibit the activity of mPGES-1.
De Simone R; Bruno I; Riccio R; Stadler K; Bauer J; Schaible AM; Laufer S; Werz O
Bioorg Med Chem; 2012 Aug; 20(16):5012-6. PubMed ID: 22795900
[TBL] [Abstract][Full Text] [Related]
5. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression.
Guerrero MD; Aquino M; Bruno I; Riccio R; Terencio MC; Payá M
Eur J Pharmacol; 2009 Oct; 620(1-3):112-9. PubMed ID: 19686718
[TBL] [Abstract][Full Text] [Related]
7. Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1.
Wu TY; Juteau H; Ducharme Y; Friesen RW; Guiral S; Dufresne L; Poirier H; Salem M; Riendeau D; Mancini J; Brideau C
Bioorg Med Chem Lett; 2010 Dec; 20(23):6978-82. PubMed ID: 20965723
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 and microsomal prostaglandin E synthase-2 expression are decreased in the cyclooxygenase-2-deficient mouse brain despite compensatory induction of cyclooxygenase-1 and Ca2+-dependent phospholipase A2.
Bosetti F; Langenbach R; Weerasinghe GR
J Neurochem; 2004 Dec; 91(6):1389-97. PubMed ID: 15584915
[TBL] [Abstract][Full Text] [Related]
9. Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template.
Wang J; Limburg D; Carter J; Mbalaviele G; Gierse J; Vazquez M
Bioorg Med Chem Lett; 2010 Mar; 20(5):1604-9. PubMed ID: 20144869
[TBL] [Abstract][Full Text] [Related]
10. Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) identified by a multistep virtual screening protocol.
Rörsch F; Wobst I; Zettl H; Schubert-Zsilavecz M; Grösch S; Geisslinger G; Schneider G; Proschak E
J Med Chem; 2010 Jan; 53(2):911-5. PubMed ID: 20025212
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo.
Kats A; Båge T; Georgsson P; Jönsson J; Quezada HC; Gustafsson A; Jansson L; Lindberg C; Näsström K; Yucel-Lindberg T
FASEB J; 2013 Jun; 27(6):2328-41. PubMed ID: 23447581
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR study of imidazoquinolines as a novel structural class of microsomal prostaglandin E₂ synthase-1 inhibitors.
Shiro T; Takahashi H; Kakiguchi K; Inoue Y; Masuda K; Nagata H; Tobe M
Bioorg Med Chem Lett; 2012 Jan; 22(1):285-8. PubMed ID: 22137787
[TBL] [Abstract][Full Text] [Related]
13. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
[TBL] [Abstract][Full Text] [Related]
14. Discovery and biological evaluation of a novel class of dual microsomal prostaglandin E2 synthase-1/5-lipoxygenase inhibitors based on 2-[(4,6-diphenethoxypyrimidin-2-yl)thio]hexanoic acid.
Hieke M; Greiner C; Dittrich M; Reisen F; Schneider G; Schubert-Zsilavecz M; Werz O
J Med Chem; 2011 Jul; 54(13):4490-507. PubMed ID: 21591611
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E₂ synthase-1 enzyme (mPGES-1).
Lauro G; Strocchia M; Terracciano S; Bruno I; Fischer K; Pergola C; Werz O; Riccio R; Bifulco G
Eur J Med Chem; 2014 Jun; 80():407-15. PubMed ID: 24794772
[TBL] [Abstract][Full Text] [Related]
16. Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.
Koeberle A; Pollastro F; Northoff H; Werz O
Br J Pharmacol; 2009 Mar; 156(6):952-61. PubMed ID: 19298395
[TBL] [Abstract][Full Text] [Related]
17. Characterization of microsomal prostaglandin E synthase 1 inhibitors.
Korotkova M; Jakobsson PJ
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533
[TBL] [Abstract][Full Text] [Related]
18. Further insights on the structural aspects of PLA(2) inhibition by gamma-hydroxybutenolide-containing natural products: a comparative study on petrosaspongiolides M-R.
Monti MC; Casapullo A; Riccio R; Gomez-Paloma L
Bioorg Med Chem; 2004 Mar; 12(6):1467-74. PubMed ID: 15018920
[TBL] [Abstract][Full Text] [Related]
19. Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production.
Ikeda-Matsuo Y; Ikegaya Y; Matsuki N; Uematsu S; Akira S; Sasaki Y
J Neurochem; 2005 Sep; 94(6):1546-58. PubMed ID: 16000148
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
De Rosa M; Giordano S; Scettri A; Sodano G; Soriente A; Pastor PG; Alcaraz MJ; Payá M
J Med Chem; 1998 Aug; 41(17):3232-8. PubMed ID: 9703468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
